Why Healthcare Providers Are Embracing Next-Generation Gout Treatment Solutions
The U.S. gout therapeutics market, valued at USD 1.40 billion in 2024, is expected to grow at a CAGR of 6.9% from 2025 to 2034, with national policy impact and strategic positioning playing a decisive role in shaping competitive outcomes. The United States remains the largest national market, driven by federal healthcare funding, strong clinical guidelines, and aggressive commercialization...
0 Comentários 0 Compartilhamentos 207 Visualizações 0 Anterior